NINDS to Purchase Affy Arrays for Fabry Disease Study

The Developmental and Metabolic Neurology Branch of the National Institutes of Neurological Disorders and Stroke plans to purchase Affymetrix human genome arrays and cycle labeling kits for an ongoing study on Fabry Disease, according to a recent government presolicitation notice.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.